• Patients & Families
• Education
• Research
• Community

• Referring Physicians
• Find a Physician
• Departments & Centers
• About URMC

• Libraries
• Alumni
• Giving

URMC  » URMC Cardiovascular Science News - September 2009 » Cardiovascular Science News Stories

• Cardiovascular Science News Stories
  • Landmark NEJM Study Finds Device Therapy Prevents Heart Failure
  • Nature Article: MicroRNAs Hold Promise for Treating Blood Vessel Disease
  • Study in Nature Medicine Establishes New Target in Diseased Arteries
  • Device Significantly Reduces Blood Pressure, Improves Heart Function
  • New $76.4M Research Building Will Facilitate Cardiovascular Science
  • Johns Hopkins’ Lowenstein Named Chief of Cardiology at Rochester
  • Cardiologist Named Acting Head of Medical Center
  • AHA Recognizes Rochester’s Cardiac, Heart Failure, Stroke Care
• Division of Cardiology
• Division of Cardiothoracic Surgery

E-newsletter signup

If you would like to receive URMC Cardiovascular Science News quarterly newsletter, sign up here.

First Name:

Last Name:

Affiliation:

Email:

Johns Hopkins’ Lowenstein Named Chief of Cardiology at Rochester

An internationally renowned scientist and clinician from The Johns Hopkins University School of Medicine has been recruited to the University of Rochester Medical Center.

Charles J. Lowenstein, M.D., was appointed to lead the Division of Cardiology, Department of Medicine, at URMC. He also serves as director of the Aab Cardiovascular Research Institute. He began in his new roles a few months ago.

“Rochester is one of very few medical centers in the country that, in addition to incredible patient care, has both excellent basic and clinical research,” Lowenstein said. “The team at the Aab CVRI is doing truly cutting-edge work, and we also are blessed with two of the best clinical investigators in arrhythmias in the world, Art Moss and Wojciech Zareba. It is rare to meet people who change the way we all practice medicine.”

Lowenstein most recently served as professor of Medicine and the Clarence Doodeman Professor of Cardiology at Johns Hopkins University.

Cardiovascular disease is a major focus of the University of Rochester Medical Center’s Strategic Plan and a significant part of the long-term vision for the clinical and research future of the Medical Center, said cardiologist Mark B. Taubman, M.D., URMC acting CEO.

“I am confident Dr. Lowenstein’s leadership will provide new dimensions to our clinical cardiology program,” Taubman said. “In addition, he will continue the expansion of our basic and translational cardiovascular research programs. With the recruitment of Dr. Lowenstein, the Aab CVRI is well positioned to become the prominent vascular biology research program in the country.”

His clinical interests include cardiac patients with acute coronary syndromes, as well as preventive cardiology strategies and novel risk factors for coronary artery disease. His laboratory explores the cellular and molecular mechanisms that regulate vascular inflammation.

Lowenstein is a member of the American Heart Association, the American Society for Clinical Investigation and the Interurban Clinical Club. He has served on grant review study sections for the American Heart Association and the National Institutes of Health.